AbbVie Inc. (ABBV) Total assets 2016–2025
AbbVie Inc. (ABBV) total assets at each fiscal year-end, per SEC filings.
$134.0BFY2025 · since FY2016: $66.1B → $134.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $134.0B | -0.9% |
| FY2024 | $135.2B | +0.3% |
| FY2023 | $134.7B | -2.9% |
| FY2022 | $138.8B | -5.3% |
| FY2021 | $146.5B | -2.7% |
| FY2020 | $150.6B | +69.0% |
| FY2019 | $89.1B | +50.1% |
| FY2018 | $59.4B | -16.2% |
| FY2017 | $70.8B | +7.1% |
| FY2016 | $66.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total liabilitiesABBV Shareholders’ equityABBV overview →